Skip to main content

Month: February 2024

SoundThinking Sets Fourth Quarter and Full Year 2023 Conference Call Date and Announces Investor Day

Q4 and FY 2023 Conference Call Set for Tuesday, February 27, 2024 at 4:30 p.m. ET Investor Day Scheduled for Thursday, March 14, 2024 at 8:00 a.m. ET in New York City FREMONT, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) —  SoundThinking, Inc. (Nasdaq: SSTI) (formerly ShotSpotter, Inc.), a leading public safety technology company, will hold a conference call on Tuesday, February 27, 2024 at 4:30 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2023. Financial results will be issued in a press release prior to the call. SoundThinking management will host an investor day for institutional investors and sell-side analysts on Thursday, March 14, 2024, at the Andaz 5th Avenue in New York, NY. Presentations are scheduled to begin at 8:00 a.m. Eastern time and end at approximately 12:00...

Continue reading

Casa Systems Develops Cloud-Native Solution to Extend Wireless Wireline Convergence Capabilities to Hybrid Cloud Environments with AWS

Cloud-native access gateway function (AGF) solution allows service providers offering both wireline and wireless services to eliminate redundant network core components and reduce capital and operating expenses. Casa’s AGF solution, now proven in private, and hybrid cloud environments, allows service providers to deploy and scale their services according to enterprise customer requirements. The work between Casa and AWS highlights the growing role of cloud-native network solutions in telecommunications.ANDOVER, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Casa Systems (Nasdaq: CASA), provider of cloud-native network solutions serving communications services providers worldwide, today announced a breakthrough in wireless wireline convergence (WWC): a successful deployment of Casa’s virtualized 5G Core control plane function on Amazon...

Continue reading

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the appointment of Peter Cicala, JD, to its Board of Directors. “Peter Cicala has deep experience in the biotechnology and pharmaceutical industry, from start-ups to big pharma, and from bench to commercialization,” said Sanjeev Luther, President and CEO of Eterna. “We are very pleased to have him join our Board to support value creation through the development of next-generation therapies using mRNA cell engineering.” Mr. Cicala’s professional expertise focuses on all aspects of pharmaceutical and biotechnology intellectual property and strategic management...

Continue reading

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan

Amendment to existing exclusive license agreement with Orion Corporation expands Tenax’s territory rights from North America, to the entire world Expanded rights position Tenax to engage potential global strategic pharmaceutical partners Improved net sales royalty rate structure, now ranging from high single-digit to low-teen percentages. Lowered maximum cost of goods Modified milestone provisions, including additional payment for regulatory approval in Japan, reflect multi-billion dollar global PH-HFpEF opportunity Neurological indications excluded from Tenax’s right of first negotiation to commercialize new applications of levosimendan developed by OrionCHAPEL HILL, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing...

Continue reading

Fresh Vine Wine Announces Fireside Chat with JW Roth, CEO of Notes Live on February 29th, at 2:00pm EST

Merger Partner Notes Live Announces Acts Include OneRepublic, Dierks Bentley, Robert Plant/Alison Krauss, Beach Boys and Steve Miller Band CHARLOTTE, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fresh Vine Wine Inc. (NYSE American: VINE) (“Fresh Vine”) today announced that it will hold a fireside chat with JW Roth, the CEO of Notes Live. The Company previously announced it had executed a definitive merger agreement (the “Merger Agreement”) to combine with Notes Live, Inc. (“Notes Live”), the Colorado-based live entertainment and hospitality company, that currently operates entertainment campuses in both the Colorado Springs, Colorado, and Atlanta, Georgia metropolitan areas. Notes Live recently announced that OneRepublic will headline its Sunset Amphitheater’s Grand Opening on Friday, August 9th. Booked exclusively in partnership...

Continue reading

KULR Extends Outstanding Note Through End of 2024; Files 14C Disclosing Corporate Actions

SAN DIEGO, Feb. 20, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a global leader in sustainable energy management, today announced that the Company and YA II PN, LTD (“Yorkville”) have agreed that the remaining amount owed Yorkville shall not be due until December 31, 2024. Additionally, KULR filed a 14C Information Statement (link here) indicating additional corporate activity. KULR management believes these updated corporate governance provisions provide the ability to act in a timely manner when a meaningful strategic, financial, or commercial opportunity arises particularly in light of recent stock market price activity and valuations. KULR CEO Michael Mo recently sat down with host Stuart Smith to discuss the corporate activity and its potential...

Continue reading

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

MIAMI, Feb. 20, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, oncology, and viral induced acute respiratory distress syndrome (ARDS), today announced the formation of a new Scientific Advisory Board to support the advancement of enobosarm, an oral novel selective androgen receptor modulator (SARM), to avoid muscle loss and augment fat loss when combined with a Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drugs for potentially higher quality weight loss. The Scientific Advisory Board brings deep and complementary knowledge in metabolic diseases, obesity, weight management, muscle preservation and physical function in addition to significant experience in clinical research and...

Continue reading

Verb’s MARKET.Live Frankie Avalon Livestream Shopping Series Attracts Large Audience of Fans and Followers

Frankie Avalon Continues His Journey of Love, Music, and Wellness Series Thursday, February 22 at 3 pm PT / 6 pm ET on MARKET.live LOS ALAMITOS, Calif. and LAS VEGAS, Feb. 20, 2024 (GLOBE NEWSWIRE) — Following the tremendous success of the inaugural livestream shopping event, Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”) is thrilled to announce the upcoming episode of the exclusive series featuring the iconic entertainer Frankie Avalon on MARKET.live. Join us for the next unforgettable experience on February 22nd at 3 pm PT / 6 pm ET. Event Details: Date/Time: Thursday, February 22nd at 3 pm PT / 6 pm ET  Hosts: Frankie Avalon and Albany Irvin (albanyirvin.com)  Products: Fruit and Veggie Supplements RSVP NOW and Be Part of the Excitement! Love and Health with Frankie Avalon...

Continue reading

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced that the Company will release its fourth quarter and fiscal year-end 2023 financial results before the markets open on Tuesday, February 27, 2024. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following:Toll free (U.S.) 1-833-316-0561International...

Continue reading

ARHT Media Announces Closing of a $250,000 Private Placement of Secured Subordinated Debentures

TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or the “Company”) (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, is pleased to announce that the Company has successfully closed a private placement (the “Private Placement”) of 2024 Series A secured subordinated debentures (the “Debentures”) for an aggregate principal amount of $250,000 (the “Principal Amount”). The Debentures mature on August 3, 2025 (the “Maturity Date”) and carry an annual interest rate of 15%, accrued and payable semi-annually on each of June 30 and December 31, in cash or shares at the option of the Company and subject to the approval of the TSX Venture Exchange (the “TSXV”). Subject...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.